Type III CRISPR-Cas Immunity: Major Differences Brushed Aside.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Trends in Microbiology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.tim.2016.09.012PMID 27773522
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector

  2016cited by this paper
• Structure of Csm2 elucidates the relationship between small subunits of CRISPR‐Cas effector complexes

  2016cited by this paper
• Structural basis for dimer formation of the CRISPR‐associated protein Csm2 of Thermotoga maritima

  2016cited by this paper
• Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas system

  2016cited by this paper
• Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA.

  2016cited by this paper
• The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA

  2016cited by this paper
• Spatiotemporal Control of Type III-A CRISPR-Cas Immunity: Coupling DNA Degradation with the Target RNA Recognition.

  2016cited by this paper
• Identification and functional study of type III-A CRISPR-Cas systems in clinical isolates of Staphylococcus aureus.

  2016cited by this paper
• CRISPR–Cas adaptation: insights into the mechanism of action

  2016cited by this paper
• RNA-activated DNA cleavage by the Type III-B CRISPR–Cas effector complex

  2016cited by this paper
• The crystal structure of Cpf1 in complex with CRISPR RNA

  2016cited by this paper
• Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering.

  2016cited by this paper
• Multiple nucleic acid cleavage modes in divergent type III CRISPR systems

  2016cited by this paper
• Crystal structures of the E. coli transcription initiation complexes with a complete bubble.

  2015cited by this paper
• Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems.

  2015cited by this paper
• Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.

  2015cited by this paper
• The structural biology of CRISPR-Cas systems.

  2015cited by this paper
• An updated evolutionary classification of CRISPR–Cas systems

  2015cited by this paper
• A Conserved Structural Chassis for Mounting Versatile CRISPR RNA-Guided Immune Responses.

  2015cited by this paper
• Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity.

  2015cited by this paper
• Crystal structure of the Csm1 subunit of the Csm complex and its single-stranded DNA-specific nuclease activity.

  2015cited by this paper
• Structures of the CRISPR-Cmr complex reveal mode of RNA target positioning

  2015cited by this paper
• 標的類似体と結合したCRISPR-Cas系Cmr複合体の結晶構造;標的類似体と結合したCRISPR-Cas系Cmr複合体の結晶構造;Crystal Structure of the CRISPR-Cas RNA Silencing Cmr Complex Bound to a Target Analog

  2015cited by this paper
• Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.

  2015cited by this paper
• Crystal structure of Cas9 in complex with guide RNA and target DNA.

  2014cited by this paper
• Essential structural and functional roles of the Cmr4 subunit in RNA cleavage by the Cmr CRISPR-Cas complex.

  2014cited by this paper
• In vitro assembly and activity of an archaeal CRISPR-Cas type I-A Cascade interference complex

  2014cited by this paper
• RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus.

  2014cited by this paper
• Crystal structure of a CRISPR RNA–guided surveillance complex bound to a ssDNA target

  2014cited by this paper
• Cmr4 is the slicer in the RNA-targeting Cmr CRISPR complex

  2014cited by this paper
• CRISPR-mediated targeted mRNA degradation in the archaeon Sulfolobus solfataricus

  2014cited by this paper
• Crystal structure of the CRISPR RNA–guided surveillance complex from Escherichia coli

  2014cited by this paper
• Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus.

  2014cited by this paper
• Structural model of a CRISPR RNA-silencing complex reveals the RNA-target cleavage activity in Cmr4.

  2014cited by this paper
• Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease

  2014cited by this paper
• An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference

  2014cited by this paper
• Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting

  2014cited by this paper
• Target RNA capture and cleavage by the Cmr type III-B CRISPR–Cas effector complex

  2014cited by this paper
• Genetic Characterization of Antiplasmid Immunity through a Type III-A CRISPR-Cas System

  2013cited by this paper
• Structure of the CRISPR Interference Complex CSM Reveals Key Similarities with Cascade

  2013cited by this paper
• Crystal structure of the Cmr2-Cmr3 subcomplex in the CRISPR-Cas RNA silencing effector complex.

  2013cited by this paper
• Structure of an RNA silencing complex of the CRISPR-Cas immune system.

  2013cited by this paper
• In vitro reconstitution of Cascade‐mediated CRISPR immunity in Streptococcus thermophilus

  2013cited by this paper
• In Vitro Reconstitution of an Escherichia coli RNA-guided Immune System Reveals Unidirectional, ATP-dependent Degradation of DNA Target*

  2013cited by this paper
• A Ruler Protein in a Complex for Antiviral Defense Determines the Length of Small Interfering CRISPR RNAs

  2013cited by this paper
• Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus.

  2013cited by this paper
• Structure of the Cmr2-Cmr3 subcomplex of the Cmr RNA silencing complex.

  2013cited by this paper
• Type I-E CRISPR-Cas Systems Discriminate Target from Non-Target DNA through Base Pairing-Independent PAM Recognition

  2013cited by this paper
• A novel interference mechanism by a type IIIB CRISPR‐Cmr module in Sulfolobus

  2013cited by this paper
• Staphylococcus epidermidis Csm1 is a 3′–5′ exonuclease

  2013cited by this paper
• Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs.

  2012cited by this paper
• Crystal structure of Cmr2 suggests a nucleotide cyclase‐related enzyme in type III CRISPR‐Cas systems

  2012cited by this paper
• Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria

  2012cited by this paper
• Structure of the Cmr2 subunit of the CRISPR-Cas RNA silencing complex.

  2012cited by this paper
• A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

  2012cited by this paper
• Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity.

  2012cited by this paper
• CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3.

  2012cited by this paper
• Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems

  2011cited by this paper
• Structural and Biochemical Analysis of Nuclease Domain of Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated Protein 3 (Cas3)*

  2011cited by this paper
• Cas3 is a single‐stranded DNA nuclease and ATP‐dependent helicase in the CRISPR/Cas immune system

  2011cited by this paper
• The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA

  2010cited by this paper
• Self vs. non-self discrimination during CRISPR RNA-directed immunity

  2009cited by this paper
• Short motif sequences determine the targets of the prokaryotic CRISPR defence system.

  2009cited by this paper
• RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex.

  2009cited by this paper
• Short motif sequences determine the targets of the prokaryotic CRISPR defence system.

  2009cited by this paper
• Classifying transcription factor targets and discovering relevant biological features

  2008cited by this paper
• Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes

  2008cited by this paper
• CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNA

  2008cited by this paper
• Phage Response to CRISPR-Encoded Resistance in Streptococcus thermophilus

  2007cited by this paper
• Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin.

  2005cited by this paper
• Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin.

  2005cited by this paper
• Nuclease Cleavage of the Upstream Half of the Nontemplate Strand DNA in an Escherichia coli Transcription Elongation Complex Causes Upstream Translocation and Transcriptional Arrest*

  1997cited by this paper

• Characterization of Five CRISPR Systems in Microcystis aeruginosa FACHB-524 with Focus on the In Vitro Antiviral Activity of One CRISPR System

  2025cites this paper
• Metal-Organic Frameworks for CRISPR/Cas9 Gene Editing Delivery: Innovations in Therapeutic and Diagnostic Applications.

  2025cites this paper
• Substrate-induced remodeling of protein disordered loops activates Csm DNases

  2025cites this paper
• CRISPR-Cas systems: Pioneering next-generation diagnostic tools for parasitic diseases.

  2025cites this paper
• Archaeal RNA processing and regulation: expanding the functional landscape

  2025cites this paper
• CARF-dependent preferential RNA cleavage by Csm6 increases drug susceptibility of mycobacteria

  2025cites this paper
• Comparative genome analysis of 15 Streptococcus thermophilus strains isolated from Turkish traditional yogurt

  2025cites this paper
• Retention of the RNA ends provides the molecular memory for maintaining the activation of the Csm complex

  2024cites this paper
• Pharmacological potential of cyclic nucleotide signaling in immunity.

  2024cites this paper
• The structural biology of type III CRISPR-Cas systems.

  2024cites this paper
• CRISPR-controlled proteases.

  2024cites this paper
• Advances in bread wheat production through CRISPR/Cas9 technology: a comprehensive review of quality and other aspects

  2023cites this paper
• Characterization of Limnospira platensis PCC 9108 R-M and CRISPR-Cas systems.

  2023cites this paper
• Harnessing CRISPR-Cas adaptation for RNA recording and beyond

  2023cites this paper
• EspB and HtpG interact with the type III-A CRISPR/Cas system of Mycobacterium tuberculosis

  2023cites this paper
• Antiviral type III CRISPR signalling via conjugation of ATP and SAM

  2023cites this paper
• Characterisation of neonatal Staphylococcus capitis NRCS-A isolates compared with non NRCS-A Staphylococcus capitis from neonates and adults

  2023cites this paper
• Endogenous CRISPR-Cas mediated in situ genome editing: State-of-the-art and the road ahead for engineering prokaryotes.

  2023cites this paper
• The influence of the copy number of invader on the fate of bacterial host cells in the antiviral defense by CRISPR-Cas10 DNases

  2023cites this paper
• Antiviral Type III CRISPR signalling via conjugation of ATP and AdoMet

  2023cites this paper
• Putative nucleotide-based second messengers in archaea

  2023cites this paper
• [Advances in the RNA-targeting CRISPR-Cas systems].

  2023cites this paper
• Regulation of CRISPR-Associated Genes by Rv1776c (CasR) in Mycobacterium tuberculosis

  2023cites this paper
• Characterisation of neonatal Staphylococcus capitis NRCS-A isolates compared with non NRCS-A Staphylococcus capitis from neonates and adults

  2022cites this paper
• Genome Editing and CRISPR/Cas System of Extremophiles and Its Applications

  2022cites this paper
• Bacterial origins of cyclic nucleotide-activated antiviral immune signaling.

  2022cites this paper
• Structure of the Saccharolobus solfataricus type III-D CRISPR effector

  2022cites this paper
• RNA-targeting CRISPR–Cas systems

  2022cites this paper
• Inactivation of Target RNA Cleavage of a III-B CRISPR-Cas System Induces Robust Autoimmunity in Saccharolobus islandicus

  2022cites this paper
• Structures of an active type III-A CRISPR effector complex.

  2022cites this paper
• Structure and engineering of the type III-E CRISPR-Cas7-11 effector complex.

  2022cites this paper
• Cyclic Nucleotide Signaling in Phage Defense and Counter-Defense.

  2022cites this paper
• Molecular and Serologic Diagnostic Technologies for SARS-CoV-2

  2022cites this paper
• Adaptation by Type III CRISPR-Cas Systems: Breakthrough Findings and Open Questions

  2022cites this paper
• CRISPR-Cas technology a new era in genomic engineering

  2022cites this paper
• Progress of CRISPR-Cas13 Mediated Live-Cell RNA Imaging and Detection of RNA-Protein Interactions

  2022cites this paper
• Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications

  2022cites this paper
• The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies

  2021cites this paper
• The Involvement of Mycobacterium Type III-A CRISPR-Cas System in Oxidative Stress

  2021cites this paper
• Exploration of the Diversity of Clustered Regularly Interspaced Short Palindromic Repeats-Cas Systems in Clostridium novyi sensu lato

  2021cites this paper
• Identification and Characterization of the CRISPR/Cas System in Staphylococcus aureus Strains From Diverse Sources

  2021cites this paper
• CRISPR/Cas13: A Novel and Emerging Tool for RNA Editing in Plants

  2021cites this paper
• Peeling the Layers Away: The Genomic Characterization of Bacillus pumilus 64-1, an Isolate With Antimicrobial Activity From the Marine Sponge Plakina cyanorosea (Porifera, Homoscleromorpha)

  2021cites this paper
• Alleviation of Neurological Disease by RNA Editing.

  2021cites this paper
• An extensive review to facilitate understanding of CRISPR technology as a gene editing possibility for enhanced therapeutic applications.

  2021cites this paper
• The Rcs stress response inversely controls surface and CRISPR–Cas adaptive immunity to discriminate plasmids and phages

  2021cites this paper
• The Cyclic Oligoadenylate Signaling Pathway of Type III CRISPR-Cas Systems

  2021cites this paper
• Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy.

  2020cites this paper
• Approaches to Study CRISPR RNA Biogenesis and the Key Players Involved.

  2020cites this paper
• Evolution and molecular mechanism of CRISPR/Cas9 systems

  2020cites this paper
• The dynamic interplay of host and viral enzymes in type III CRISPR-mediated cyclic nucleotide signalling

  2020cites this paper
• Regulation of the RNA and DNA nuclease activities required for Pyrococcus furiosus Type III-B CRISPR–Cas immunity

  2020cites this paper
• Reprogramming the endogenous type III-A CRISPR-Cas system for genome editing, RNA interference and CRISPRi screening in Mycobacterium tuberculosis

  2020cites this paper
• Pathogenic and antimicrobial resistance genes in Streptococcus oralis strains revealed by comparative genome analysis.

  2020cites this paper
• Applications of CRISPR-Cas systems in Lactic Acid Bacteria.

  2020cites this paper
• Abortive Infection: Bacterial Suicide as an Antiviral Immune Strategy.

  2020cites this paper
• Type III-A CRISPR-associated protein Csm6 degrades cyclic hexa-adenylate activator using both CARF and HEPN domains

  2020cites this paper
• Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation

  2020cites this paper
• Targeted RNA Knockdown by a Type III CRISPR-Cas Complex in Zebrafish

  2020cites this paper
• DNA targeting by subtype I-D CRISPR–Cas shows type I and type III features

  2020cites this paper
• Comparative CRISPR type III-based knockdown of essential genes in hyperthermophilic Sulfolobales and the evasion of lethal gene silencing

  2020influential citation
• Type III-A CRISPR systems as a versatile gene knockdown technology

  2020cites this paper
• CRISPR-Cas adaptive immune systems in Sulfolobales: genetic studies and molecular mechanisms

  2020cites this paper
• CRISPR–Cas immune systems and genome engineering

  2020cites this paper
• Mycobacterium tuberculosis CRISPR/Cas system Csm1 holds clues to the evolutionary relationship between DNA polymerase and cyclase activity.

  2020cites this paper
• CRISPR Pioneers Win 2020 Nobel Prize for Chemistry

  2020cites this paper
• Second Messenger cA4 Formation within the Composite Csm1 Palm Pocket of Type III-A CRISPR-Cas Csm Complex and Its Release Path.

  2019cites this paper
• Acquired and Innate Immunity in Prokaryotes Define Their Evolutionary Story

  2019cites this paper
• Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase

  2019cites this paper
• Activation of a Transcription-Dependent CRISPR-Cas System

  2019cites this paper
• CRISPR-Cas IIIA Csm 6 CA RF Domain Is a Ring Nuclease Triggering Stepwise cA 4 Cleavage with ApA > p Formation Terminating RNase Activity Graphical

  2019cites this paper
• Cmr3 regulates the suppression on cyclic oligoadenylate synthesis by tag complementarity in a Type III-B CRISPR-Cas system

  2019cites this paper
• CRISPR-Cas III-A Csm6 CARF Domain Is a Ring Nuclease Triggering Stepwise cA4 Cleavage with ApA>p Formation Terminating RNase Activity.

  2019cites this paper
• CRISPR-Cas in Streptococcus pyogenes

  2019cites this paper
• Genetic Dissection of the Type III-A CRISPR-Cas System Csm Complex Reveals Roles of Individual Subunits.

  2019cites this paper
• Target preference of Type III-A CRISPR-Cas complexes at the transcription bubble

  2019cites this paper
• In vitro assembly of thermostable Csm complex in CRISPR-Cas type III/A system.

  2019cites this paper
• Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.

  2019influential citation
• CRISPR technology to combat plant RNA viruses: A theoretical model for Potato virus Y (PVY) resistance.

  2019cites this paper
• Target sequence requirements of a type III-B CRISPR-Cas immune system

  2019cites this paper
• A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator

  2019cites this paper
• Harnessing type I CRISPR–Cas systems for genome engineering in human cells

  2019cites this paper
• CRISPR Complex Subunit Csm3 from Staphylococcus epidermidis RP62a

  2019cites this paper
• Characterization of a novel type III effector provides new insights into the allosteric activation and suppression of the Cas10 DNase

  2019cites this paper
• Spacer acquisition from RNA mediated by a natural reverse transcriptase-Cas1 fusion protein associated with a type III-D CRISPR–Cas system in Vibrio vulnificus

  2019cites this paper
• An overview and metanalysis of machine and deep learning-based CRISPR gRNA design tools

  2019cites this paper
• Lawrence Berkeley National Laboratory Recent Work Title Target preference of Type IIIA CRISPR-Cas complexes at the transcription bubble

  2019cites this paper
• The host-encoded RNase E endonuclease as the crRNA maturation enzyme in a CRISPR–Cas subtype III-Bv system

  2018cites this paper
• Tolerance of Sulfolobus SMV1 virus to the immunity of I-A and III-B CRISPR-Cas systems in Sulfolobus islandicus

  2018cites this paper
• A Type III-B Cmr effector complex catalyzes the synthesis of cyclic oligoadenylate second messengers by cooperative substrate binding

  2018cites this paper
• Regulation of the CRISPR-Associated Genes by Rv2837c (CnpB) via an Orn-Like Activity in Tuberculosis Complex Mycobacteria

  2018cites this paper
• Control of cyclic oligoadenylate synthesis in a type III CRISPR system

  2018cites this paper
• Shooting the messenger: RNA-targetting CRISPR-Cas systems

  2018cites this paper
• Insights into RNA-processing pathways and associated RNA-degrading enzymes in Archaea

  2018cites this paper
• Molecular mechanisms of III-B CRISPR-Cas systems in archaea.

  2018cites this paper
• Structural insights into the CRISPR-Cas-associated ribonuclease activity of Staphylococcus epidermidis Csm3 and Csm6: a step for the development of novel genome editing tool.

  2018cites this paper
• Cryo-EM structure of Csm effector complex

  2018cites this paper
• Surveillance and Elimination of Bacteriophage Contamination in an Industrial Fermentation Process

  2018cites this paper
• Harnessing “A Billion Years of Experimentation”: The Ongoing Exploration and Exploitation of CRISPR–Cas Immune Systems

  2018influential citation
• The nuts and bolts of the Haloferax CRISPR-Cas system I-B

  2018cites this paper